EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Do Tobacco Companies Have an Incentive to Promote “Harm Reduction” Products?: The Role of Competition

David T Levy iD, Frances Thirlway, David Sweanor, Alex Liber iD, Luz Maria Sanchez-Romero iD, Rafael Meza iD, Clifford E Douglas, K Michael Cummings

Nicotine and Tobacco Research · 2023

DOI: 10.1093/ntr/ntad014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nicotine and Tobacco Research, 2023. Verfasst von David T Levy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Department, Lombardi Comprehensive Center, Georgetown University, Washington, DC, USA. Hauptthemen laut MEDLINE: Tobacco Products, Vaping, Electronic Nicotine Delivery Systems. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Some cigarette companies have started to talk about replacing cigarettes with less harmful alternatives, which might include nicotine vaping products (NVPs), heated tobacco products (HTPs), and oral nicotine delivery products. We consider market competition as a primary driver of whether cigarette companies follow through on their stated intentions. Aims and Methods We focus on the behavior of cigarette companies in the United States. We compare competition in the pre- and post-2012 time periods, analyze the impact of the growth in NVPs on smoking prevalence and cigarette company profits, and examine the potential future role of competition.

Results

Since 2006, consumers have broadened their use of non-combustible nicotine delivery products (NCNDPs) to include, inter alia, NVPs, HTPs, and oral nicotine pouches. U.S. cigarette companies have acquired major stakes in each of these product categories which corresponds to a period of rapidly declining adult smoking prevalence, especially among younger adults (ages 18–24 years). The shifting dynamics of the nicotine product marketplace are also reflected in cigarette company stock prices. While cigarette companies are likely to promote HTPs and nicotine delivery products over NVPs, their incentives will be directly related to competition from independent firms, which in turn will depend on government regulation.

Conclusions

Although cigarette companies will back alternatives to combusted tobacco when threatened by competition, the prospects for their lasting conversion to NCNDPs will depend on the extent of such competition, which will be influenced by government regulation of tobacco products.

Implications

Regulations that limit competition from independent firms while also protecting cigarette company profits risk slowing or even reversing recent declines in smoking, especially among youth and young adults. Regulations that reduce the appeal and addictiveness of combusted tobacco products, such as higher cigarette taxes or a reduced nicotine standard, will encourage smokers to quit and/or switch to less harmful non-combusted forms of tobacco. The regulation of non-combustible nicotine delivery products and cigarettes should be proportionate to their relative risks, so that smokers have incentives to switch from combustibles to safer alternatives, and cigarette companies have incentives to promote safer products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tobacco ProductsVapingElectronic Nicotine Delivery SystemsYoung AdultAdolescentHumansUnited StatesNicotineMotivationSmoking

Substanzen

Nicotine

Autor:innen und Institutionen

  • Oncology Department, Lombardi Comprehensive Center, Georgetown University, Washington, DC, USA.
  • Sociology Department, University of York, Heslington, York, UK.
  • Centre for Health Law, Policy and Ethics, University of Ottawa, Ottawa, Ontario, Canada.
  • Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
  • Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, USA.
  • Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charlestown, SC, USA.

ORCID-Profile: David T Levy, Alex Liber, Luz Maria Sanchez-Romero, Rafael Meza

Förderung

  • Cancer Research UK
  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Levy, D. T., Thirlway, F., Sweanor, D., Liber, A., Maria Sanchez-Romero, L., Meza, R., Douglas, C. E., & Michael Cummings, K. (2023). Do Tobacco Companies Have an Incentive to Promote “Harm Reduction” Products?: The Role of Competition. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntad014

Vancouver

Levy DT, Thirlway F, Sweanor D, Liber A, Maria Sanchez-Romero L, Meza R, et al. Do Tobacco Companies Have an Incentive to Promote “Harm Reduction” Products?: The Role of Competition. Nicotine and Tobacco Research. 2023. doi:10.1093/ntr/ntad014

BibTeX
@article{Levy2023,
  author = {Levy, David T and Thirlway, Frances and Sweanor, David and Liber, Alex and Maria Sanchez-Romero, Luz and Meza, Rafael and Douglas, Clifford E and Michael Cummings, K},
  title = {Do Tobacco Companies Have an Incentive to Promote “Harm Reduction” Products?: The Role of Competition},
  journal = {Nicotine and Tobacco Research},
  year = {2023},
  doi = {10.1093/ntr/ntad014}
}
Kostenlos starten →